Gapping down
In reaction to disappointing earnings/guidance: SPRT -13.5%, TCS -9.6%, SEED -4.9%, AZZ -0.6%, MSM -0.4%.
A few Euro drug names showing weakness: SNY -1%, GSK -0.6% .
Select oil/gas related names showing early weakness: TOT -0.9%, WLT -0.8%, CAM -0.6% (Cameron downgraded to Outperform at RBC Capital Mkts; tgt raised to $68), RDS.A -0.5%, COP -0.2% (lowers Q4 production guidance to ~1475 MBOED; no long-term impact to production due to weather related downtime).
Other news: RBCN -6% (announces sale of $28.2 mln of common stock), VRS -5.3% (modestly pulling back), BLDP -4.9% (modestly pulling back), JKS -3% (still checking), LAND -2.9% (announced monthly dividend lower than prior month), OXBT -2.7% (still checking), SI -1.3% (still checking), NOK -0.9% (still checking), NKE -0.9% (still checking), MSFT -0.8% (Mulally said he will not leave for Microsoft), RSE -0.7% ( prices 7 mln shares of common stock of $19.50 per share), PGR -0.5% (still checking), FB -0.4% ( has acquired India startup Little Eye Labs, according to reports), PM -0.3% (following late weakness on potential China smoking ban).
Analyst comments: SHOO -3.7% (downgraded to Neutral from Overweight at Piper Jaffray), TWTR -3.2% (downgraded to Sell from Hold at Cantor Fitzgerald), NBIX -2.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $16), DF -1.9% (downgraded to Hold from Buy at Deutsche Bank), AMBA -1.7% (downgraded to Hold from Buy at Needham), THC -1.3% (Tenet downgraded to Market Perform from Outperform at Raymond James), GNRC -0.9% (downgraded to Hold from Buy at Stifel), ZTS -0.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley), KEY -0.7% (KeyCorp downgraded to Perform from Outperform at Oppenheimer), MCD -0.6% (McDonald's downgraded to Market Perform from Outperform at Wells Fargo), LLY -0.6% ( Lilly downgraded to Underperform from Market Perform at BMO Capital), USB -0.4% (downgraded to Neutral from Outperform at Credit Suisse)
A few Euro drug names showing weakness: SNY -1%, GSK -0.6% .
Select oil/gas related names showing early weakness: TOT -0.9%, WLT -0.8%, CAM -0.6% (Cameron downgraded to Outperform at RBC Capital Mkts; tgt raised to $68), RDS.A -0.5%, COP -0.2% (lowers Q4 production guidance to ~1475 MBOED; no long-term impact to production due to weather related downtime).
Other news: RBCN -6% (announces sale of $28.2 mln of common stock), VRS -5.3% (modestly pulling back), BLDP -4.9% (modestly pulling back), JKS -3% (still checking), LAND -2.9% (announced monthly dividend lower than prior month), OXBT -2.7% (still checking), SI -1.3% (still checking), NOK -0.9% (still checking), NKE -0.9% (still checking), MSFT -0.8% (Mulally said he will not leave for Microsoft), RSE -0.7% ( prices 7 mln shares of common stock of $19.50 per share), PGR -0.5% (still checking), FB -0.4% ( has acquired India startup Little Eye Labs, according to reports), PM -0.3% (following late weakness on potential China smoking ban).
Analyst comments: SHOO -3.7% (downgraded to Neutral from Overweight at Piper Jaffray), TWTR -3.2% (downgraded to Sell from Hold at Cantor Fitzgerald), NBIX -2.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $16), DF -1.9% (downgraded to Hold from Buy at Deutsche Bank), AMBA -1.7% (downgraded to Hold from Buy at Needham), THC -1.3% (Tenet downgraded to Market Perform from Outperform at Raymond James), GNRC -0.9% (downgraded to Hold from Buy at Stifel), ZTS -0.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley), KEY -0.7% (KeyCorp downgraded to Perform from Outperform at Oppenheimer), MCD -0.6% (McDonald's downgraded to Market Perform from Outperform at Wells Fargo), LLY -0.6% ( Lilly downgraded to Underperform from Market Perform at BMO Capital), USB -0.4% (downgraded to Neutral from Outperform at Credit Suisse)